Upstream Bio Inc banner

Intrinsic Value

Is UPB undervalued or overvalued?

See the intrinsic value estimate for Upstream Bio Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

UPB Intrinsic Value
LOCKED
Unlock
Today vs. history

UPB looks overvalued.
But is it expensive by its own standards?

See how today’s valuation compares with UPB’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor UPB
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Current Price $2.98
Intrinsic Value Locked
Margin of Safety 20% Locked
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to UPB

Fundamental Analysis

What Upstream Bio Does

Biotechnology Health Care

Upstream Bio is a clinical-stage biotechnology company that is developing antibody medicines for severe inflammatory and respiratory diseases. Its lead programs are aimed at the biology that drives conditions such as asthma and chronic sinus disease, with the goal of calming the overactive immune signals that keep these illnesses going.

Headquarters
United States of America US
Employees
75
IPO date
Oct 11, 2024
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Upstream Bio Inc

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

UPB Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one UPB stock?

The intrinsic value for Upstream Bio Inc (UPB) under the Base Case is hidden USD.

Is UPB stock undervalued or overvalued?

Compared with the current market price of 2.98 USD, the stock appears hidden.

Back to Top